MYOVANT SCIENCES LTD's ticker is MYOV and the CUSIP is G637AM102. A total of 111 filers reported holding MYOVANT SCIENCES LTD in Q4 2021. The put-call ratio across all filers is 3.86 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $98,157,000 | +23.1% | 5,465,262 | -14.8% | 0.02% | +31.2% |
| Q2 2022 | $79,756,000 | +3.6% | 6,416,368 | +11.0% | 0.02% | +23.1% |
| Q1 2022 | $77,011,000 | -18.4% | 5,781,624 | -4.7% | 0.01% | -13.3% |
| Q4 2021 | $94,414,000 | -37.2% | 6,063,802 | -9.4% | 0.02% | -42.3% |
| Q3 2021 | $150,232,000 | +1.2% | 6,694,879 | +2.6% | 0.03% | +4.0% |
| Q2 2021 | $148,508,000 | +27.6% | 6,522,074 | +15.3% | 0.02% | +25.0% |
| Q1 2021 | $116,373,000 | +13.5% | 5,654,749 | +52.3% | 0.02% | +5.3% |
| Q4 2020 | $102,566,000 | +232.8% | 3,713,451 | +69.3% | 0.02% | +216.7% |
| Q3 2020 | $30,820,000 | -30.8% | 2,193,563 | +1.5% | 0.01% | -40.0% |
| Q2 2020 | $44,543,000 | +84.2% | 2,160,202 | -32.5% | 0.01% | +66.7% |
| Q1 2020 | $24,180,000 | -56.9% | 3,202,480 | -11.4% | 0.01% | -50.0% |
| Q4 2019 | $56,089,000 | +214.3% | 3,614,021 | +5.3% | 0.01% | +200.0% |
| Q3 2019 | $17,846,000 | -45.9% | 3,431,591 | -5.8% | 0.00% | -42.9% |
| Q2 2019 | $32,973,000 | – | 3,643,438 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NovaQuest Capital Management, L.L.C. | 3,474,645 | $26,234,000 | 74.74% |
| Opaleye Management Inc. | 656,000 | $4,953,000 | 1.31% |
| Ghost Tree Capital, LLC | 585,000 | $4,417,000 | 1.17% |
| Cormorant Asset Management, LP | 2,600,000 | $19,630,000 | 0.91% |
| Bellevue Group AG | 4,815,109 | $36,354,000 | 0.70% |
| Values First Advisors, Inc. | 32,818 | $247,777 | 0.30% |
| Amia Capital LLP | 41,970 | $317,000 | 0.28% |
| Ikarian Capital, LLC | 450,000 | $3,398,000 | 0.26% |
| Eventide Asset Management | 800,000 | $6,040,000 | 0.20% |
| Rock Springs Capital Management LP | 500,000 | $3,775,000 | 0.16% |